Identification of HLA-A11-restricted HIV-1-specific cytotoxic T-lymphocyte epitopes in China

被引:6
|
作者
Wang, Shaoyang
Sun, Yongtao [1 ]
Zhai, Song
Zhuang, Yan
Zhao, Shuguang
Kang, Whenzhen
Li, Xinhong
Huang, Dedong
Yu, Xu G.
Walker, Bruce D.
Altfeld, Marcus A.
机构
[1] Fourth Mil Med Univ, Tangdu Hosp, Dept Infect Dis, Xian 710038, Peoples R China
[2] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Partners AIDS Res Ctr, Boston, MA 02129 USA
关键词
HIV; cytotoxic T-lymphocyte; epitopes; enzyme-linked immunospot (ELISPOT) assay; intracellular gamma interferon staining (ICS);
D O I
10.2174/157016207779316404
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To fully define HLA-All-restricted HIV-1- specific cytotoxic T-lymphocyte epitopes in China, a method combining the enzyme-linked immunospot (ELISPOT) assay with intracellular gamma interferon staining (ICS) of peripheral blood mononuclear cells (PBMC) was used to map the optimal epitopes targeted by ELISPOT and then to define the FILA restriction of epitopes by ICS. A novel HLA-All-restricted CTL epitope and five other published HLA-All -restricted epitopes previously identified by reverse immunogenetics or other methods were defined. The approach of integrating ELISPOT with ICS is both convenient and useful for the characterization of CTL responses to HIV-1 infection; this method is practical for defining novel epitopes and facilitates in developing new strategies for future vaccine design in China and other Asian countries.
引用
收藏
页码:119 / 128
页数:10
相关论文
共 50 条
  • [1] HIV-1-SPECIFIC CYTOTOXIC T-LYMPHOCYTE RESPONSES IN THE FIRST YEAR OF LIFE
    LUZURIAGA, K
    HOLMES, D
    HEREEMA, A
    WONG, J
    PANICALI, DL
    SULLIVAN, JL
    JOURNAL OF IMMUNOLOGY, 1995, 154 (01): : 433 - 443
  • [2] CHARACTERIZATION OF THE HIV-1-SPECIFIC CYTOTOXIC T-LYMPHOCYTE RESPONSE DURING ACUTE INFECTION
    SAFRIT, JT
    ANDREWS, CA
    LEE, A
    KOUP, RA
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 22 - 22
  • [3] Population coverage by HLA class-I restricted cytotoxic T-lymphocyte epitopes
    Jeffrey Longmate
    Joanne York
    Corinna La Rosa
    Radhika Krishnan
    Ming Zhang
    David Senitzer
    Don J. Diamond
    Immunogenetics, 2001, 52 : 165 - 173
  • [4] Population coverage by HLA class-I restricted cytotoxic T-lymphocyte epitopes
    Longmate, J
    York, J
    La Rosa, C
    Krishnan, R
    Zhang, M
    Senitzer, D
    Diamond, DJ
    IMMUNOGENETICS, 2001, 52 (3-4) : 165 - 173
  • [5] Identification of novel HLA-A11-restricted T-cell epitopes in the Ebola virus nucleoprotein
    Li, Dan
    Li, Pei
    Song, Nianping
    Jiang, Yuting
    Zeng, Yang
    Zhao, Guangyu
    Fa, Yunzhi
    Ye, Huahu
    Lone, Yuchun
    Zhou, Yusen
    Sun, Shihui
    Zeng, Lin
    MICROBES AND INFECTION, 2019, 21 (01) : 56 - 62
  • [6] DIFFERENT PATTERNS OF HIV-1-SPECIFIC CYTOTOXIC T-LYMPHOCYTE ACTIVITY AFTER PRIMARY INFECTION
    LAMHAMEDICHERRADI, S
    CULMANNPENCIOLELLI, B
    GUY, B
    LY, TD
    GOUJARD, C
    GUILLET, JG
    GOMARD, E
    AIDS, 1995, 9 (05) : 421 - 426
  • [7] Identification of a novel HLA B*57 restricted cytotoxic T-lymphocyte epitope within HIV-1 rev
    Makadzange, AT
    Gillespie, G
    Kimani, J
    Kiama, P
    Easterbrook, P
    Bwayo, JJ
    Rowland-Jones, SL
    AIDS, 2006, 20 (03) : 462 - 464
  • [8] Identification of a novel HLA-A24-restricted cytotoxic T-lymphocyte epitope within HIV-1 Nef
    Goulder, PJR
    Edwards, A
    Phillips, RE
    McMichael, AJ
    AIDS, 1997, 11 (15) : 1883 - 1884
  • [9] HIV-1-specific cytotoxic T lymphocyte (CTL) responses against immunodominant optimal epitopes slow the progression of AIDS in China
    Zhai, Song
    Zhuang, Yan
    Song, Yang
    Li, Shu
    Huang, Dedong
    Kang, Wenzhen
    Li, Xinhong
    Liao, Qi
    Liu, Yanhou
    Zhao, Zhongfang
    Lu, Yichen
    Sun, Yongtao
    CURRENT HIV RESEARCH, 2008, 6 (04) : 335 - 350
  • [10] Recognition of protease by HIV-1-specific cytotoxic T-lymphocyte is influenced by protease inhibitor resistance mutations
    Mueller, S. M.
    Schatz, B.
    Eismann, K.
    Bergmann, S.
    Walter, H.
    Schmidt, B.
    Korn, K.
    Schmucker, M.
    Spriewald, B.
    Harrer, E.
    Harrer, T.
    ANTIVIRAL THERAPY, 2008, 13 (04) : A89 - A89